Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 61401-61450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05737511
Efficacy of Hydroxyzine for Patients With Panic Disorder
PHASE4Not yet recruiting
80 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor0 locations
NCT06230263
Comparative Functional Vision Outcomes: DAILIES TOTAL1 Toric vs. Spherical Lenses in Asian Astigmatic Patients
NARecruiting
39 participants
Started: Dec 30, 2023 · Completed: Apr 1, 2024
1 condition1 sponsor1 location
NCT06110663
A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
PHASE3Not yet recruiting
314 participants
Started: Dec 30, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor0 locations
NCT06146413
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger
PHASE2Not yet recruiting
150 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06164535
The Effects of DPPIs on Cognitive Function of Diabetic Patients
PHASE4Not yet recruiting
105 participants
Started: Dec 30, 2023 · Completed: Jul 15, 2024
1 condition3 sponsors1 location
NCT06085885
Tinnitus and Cochlear Implants
N/AEnrolling by invitation
50 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06169410
Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer
PHASE4Recruiting
140 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06174792
Evaluation of the Efficacy and Safety of Drospirenone in the Treatment of Adenomyosis
N/ANot yet recruiting
40 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05487924
Stroke Volume Variation- Guided Hemodynamic Therapy Versus Oxygen Extraction Ratio-guided Hemodynamic Therapy
NANot yet recruiting
610 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors0 locations
NCT06170008
Efficacy of a Transparent Silicone Membrane With Physical Microstructure for Second-degree Burn Wounds and Skin Graft Wounds
NANot yet recruiting
40 participants
Started: Dec 30, 2023 · Completed: Dec 30, 2026
2 conditions1 sponsor0 locations
NCT05950945
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
PHASE3Recruiting
250 participants
Started: Dec 30, 2023 · Completed: Oct 1, 2027
1 condition2 sponsors84 locations
NCT05991570
Thoracoscopic Exploration in Comparison to Exploratory Thoracotomy in Chest Trauma
NANot yet recruiting
40 participants
Started: Dec 30, 2023 · Completed: Jan 15, 2026
1 condition1 sponsor0 locations
NCT06232356
Screening for Lung Health by a Mobile Device
N/ARecruiting
275 participants
Started: Dec 30, 2023 · Completed: Oct 31, 2024
2 conditions1 sponsor2 locations
NCT06181383
Phenobarbital Versus Levetiracetam Neonatal Convulsion
N/ANot yet recruiting
42 participants
Started: Dec 30, 2023 · Completed: May 30, 2025
1 condition1 sponsor0 locations
NCT06186739
Rehabilitation Training Participated by Caregivers in Ischemic Stroke: a Randomized Controlled Trial to Test the Effect of Home-based Rehabilitation Intervention on Physical Function.
NANot yet recruiting
58 participants
Started: Dec 30, 2023 · Completed: Aug 30, 2024
2 conditions2 sponsors0 locations
NCT06773663
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
PHASE1/PHASE2Recruiting
150 participants
Started: Dec 30, 2023 · Completed: Oct 30, 2026
2 conditions1 sponsor1 location
NCT06194422
Psychiatric Comorbidities in Children With Generalized Epilepsy
N/ANot yet recruiting
62 participants
Started: Dec 30, 2023 · Completed: Mar 24, 2025
1 condition1 sponsor0 locations
NCT07090746
Evaluation of Dentoalveolar Changes of Clear Aligners Versus Fixed Orthodontic Appliances on Skeletal Class I Non-extraction Patients With Dental Crowding
NAActive, not recruiting
24 participants
Started: Dec 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06217341
Bispectral Index and Emergence Agitation in Spinal Surgeries
N/ARecruiting
60 participants
Started: Dec 29, 2023 · Completed: Apr 29, 2024
3 conditions1 sponsor1 location
NCT06149312
Feasibility of an Advance Care Planning Intervention
NARecruiting
120 participants
Started: Dec 29, 2023 · Completed: Dec 29, 2024
1 condition1 sponsor1 location
NCT06506721
Comparison Between Two Medical Devices for Labor Induction After Previous C-section
NARecruiting
137 participants
Started: Dec 29, 2023 · Completed: Dec 28, 2026
3 conditions1 sponsor1 location
NCT05991193
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
N/ARecruiting
100 participants
Started: Dec 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
PHASE1/PHASE2Recruiting
142 participants
Started: Dec 29, 2023 · Completed: Jun 29, 2027
1 condition1 sponsor79 locations
NCT06090539
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
PHASE1/PHASE2Recruiting
308 participants
Started: Dec 29, 2023 · Completed: Oct 28, 2028
1 condition1 sponsor33 locations
NCT06142357
Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
N/AActive, not recruiting
188 participants
Started: Dec 29, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor16 locations
NCT05934318
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
NARecruiting
2,960 participants
Started: Dec 29, 2023 · Completed: Dec 30, 2026
6 conditions4 sponsors1 location
NCT06110793
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
PHASE1/PHASE2Recruiting
43 participants
Started: Dec 29, 2023 · Completed: Nov 30, 2026
1 condition2 sponsors7 locations
NCT06236932
"Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, SIDERALE"
NARecruiting
100 participants
Started: Dec 29, 2023 · Completed: Oct 29, 2026
5 conditions5 sponsors4 locations
NCT06216873
Collecting the Results of Multiple Trauma Patients and Find the Correlation of Morality and Mobility
N/ARecruiting
400 participants
Started: Dec 29, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT06158087
To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms
NARecruiting
130 participants
Started: Dec 29, 2023 · Completed: Jun 20, 2026
1 condition3 sponsors1 location
NCT06128239
Comparing Suicide Prevention Interventions to Guide Follow-up Care: The SPRING Trial
NAActive, not recruiting
854 participants
Started: Dec 29, 2023 · Completed: Mar 31, 2026
3 conditions4 sponsors1 location
NCT06942988
Efficacy of Intracavernous Platelet-rich Plasma Injection in the Treatment of Erectile Dysfunction
PHASE3Active, not recruiting
34 participants
Started: Dec 29, 2023 · Completed: Jul 29, 2025
1 condition2 sponsors1 location
NCT06184711
McNeill Dysphagia Therapy Program Combined With Transcranial Magnetic Stimulation
NANot yet recruiting
30 participants
Started: Dec 29, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06196736
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
PHASE3Recruiting
432 participants
Started: Dec 29, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06183697
Multi-omics Database Construction of Healthy Korean Volunteers
N/ARecruiting
3,000 participants
Started: Dec 29, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06178679
Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
PHASE3Recruiting
175 participants
Started: Dec 29, 2023 · Completed: Jul 30, 2024
1 condition2 sponsors1 location
NCT06225921
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
PHASE1Recruiting
6 participants
Started: Dec 29, 2023 · Completed: Jan 15, 2025
1 condition1 sponsor1 location
NCT06161753
The Costs and Effectiveness of Cognitive Functional Therapy for People with Persistent Low Back Pain in Coventry.
NAActive, not recruiting
61 participants
Started: Dec 28, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06170489
A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)
PHASE3Recruiting
185 participants
Started: Dec 28, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06142188
Relmacabtagene Autoleucel in Hematologic Malignancies
N/ANot yet recruiting
150 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2038
3 conditions1 sponsor2 locations
NCT06440902
Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA
PHASE2Recruiting
1,100 participants
Started: Dec 28, 2023 · Completed: Sep 1, 2028
1 condition1 sponsor1 location
NCT06352801
Effectiveness of Self-Compassion Intervention on Enhancing Self-Compassion and Psychological Well-Being of Children With Attention Deficit/Hyperactivity Disorder
NARecruiting
100 participants
Started: Dec 28, 2023 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT05669001
A Study of TCD601 in de Novo Renal Transplant Recipients
PHASE2Active, not recruiting
90 participants
Started: Dec 28, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor27 locations
NCT06172322
A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
PHASE1Recruiting
42 participants
Started: Dec 28, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06176781
The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS
PHASE3Not yet recruiting
880 participants
Started: Dec 28, 2023 · Completed: May 30, 2025
1 condition1 sponsor0 locations
NCT06169371
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
PHASE4Recruiting
50 participants
Started: Dec 28, 2023 · Completed: Nov 30, 2030
1 condition1 sponsor2 locations
NCT06148896
Combining Physiotherapy Group Exercise With Acceptance and Commitment Therapy in Elderly With Chronic Low Back Pain
NARecruiting
86 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06241755
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE3Recruiting
412 participants
Started: Dec 28, 2023 · Completed: Sep 3, 2026
1 condition2 sponsors1 location
NCT05997017
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
PHASE2Recruiting
29 participants
Started: Dec 28, 2023 · Completed: Oct 31, 2026
6 conditions1 sponsor9 locations
NCT06153420
Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
PHASE2Recruiting
450 participants
Started: Dec 28, 2023 · Completed: Dec 9, 2025
1 condition1 sponsor53 locations